Home
Conditions
Gram-Positive Bacterial Infections

Clinical trial condition

Gram-Positive Bacterial Infections

Explore clinical trials studying Gram-Positive Bacterial Infections. Study availability and eligibility vary by location and protocol.

2,601 public trials 262 recruiting studies

Refine in advanced search Browse all conditions

Gram-Positive Bacterial Infections trial results

Completed

Evaluation of Boostrix™10 Years After Previous Booster Vaccination

NCT01147900

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
Locations: GSK Investigational Site Brussels, Belgium

GSK Investigational Site Leuven, Belgium

GSK Investigational Site Wilrijk, Belgium

View Trial Details

Completed

Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)

NCT01248884

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations: GSK Investigational Site Santo Domingo, Dominican Republic

GSK Investigational Site Santo Domingo, Distrito Nacional, Dominican Republic

GSK Investigational Site Espoo, Finland

GSK Investigational Site Helsinki, Finland

View all 16 locations

View Trial Details

Completed

Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants

NCT01090453

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
Locations: GSK Investigational Site Vancouver, British Columbia, Canada

GSK Investigational Site Winnipeg, Manitoba, Canada

GSK Investigational Site Hamilton, Ontario, Canada

GSK Investigational Site Aix-en-Provence, France

View all 34 locations

View Trial Details

Completed

A Study to Assess How Much Drug Reaches the Blood When Given From Symbicort pMDI With Spacer Compared to That of Symbicort pMDI Without Spacer in Healthy Volunteers

NCT02934607

Conditions: Anthrax, Asthma, Bacillaceae Infections, +18 more
Locations: Research Site Harrow, United Kingdom

View Trial Details

Completed

Evaluation of a Booster Dose of Pneumococcal Vaccine Formulations in Young Adults

NCT00896064

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations: GSK Investigational Site Ghent, Belgium

View Trial Details

Completed

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6-12wks of Age

NCT00808444

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations: GSK Investigational Site Kuala Lumpur, Malaysia

GSK Investigational Site Seremban, Negeri Sembilan, Malaysia

GSK Investigational Site Singapore

GSK Investigational Site Singapore

View Trial Details

Completed

US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease

NCT00282295

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +12 more
Locations: GSK Investigational Site Chandler, Arizona, United States

GSK Investigational Site Little Rock, Arkansas, United States

GSK Investigational Site Fountain Valley, California, United States

GSK Investigational Site Golden, Colorado, United States

View all 24 locations

View Trial Details

Completed

Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age.

NCT00829010

Conditions: Acquired Immunodeficiency Syndrome, Bacterial Infections, Bacterial Infections and Mycoses, +19 more
Locations: GSK Investigational Site Soweto, Gauteng, South Africa

View Trial Details

Completed

Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children

NCT01245049

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
Locations: GSK Investigational Site St Austell, Cornwall, United Kingdom

GSK Investigational Site Southampton, Hampshire, United Kingdom

GSK Investigational Site Axbridge, Somerset, United Kingdom

GSK Investigational Site Taunton, Somerset, United Kingdom

View all 13 locations

View Trial Details

Completed

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Healthy HIV Negative Adolescents

NCT00950612

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +4 more
Locations: GSK Investigational Site Worcester, Western Province, South Africa

View Trial Details

Gram-Positive Bacterial Infections

Gram-Positive Bacterial Infections trial results

Related conditions